About this Research Topic
We are delighted to present the inaugural Frontiers in Pharmacology 'Women in Pharmacoepidemiology” series of article collections.
This Research Topic is part of the Women in Pharmacology series. Other titles in the series are:
Women in Obstetric and Pediatric Pharmacology: 2021
Women in Inflammation Pharmacology: 2021
Women in Integrative and Regenerative Pharmacology: 2021
Women in Pharmacology of Anti-Cancer Drugs: 2021
Women in Pharmacology of Infectious Diseases: 2021
Women in Drug Metabolism and Transport: 2021
Women in Cardiovascular and Smooth Muscle Pharmacology: 2021
Women in Inflammation Pharmacology: 2021
Women in Pharmacogenetics and Pharmacogenomics: 2021
Women in Neuropharmacology: 2021
Women in Drugs Outcomes Research and Policies: 2021
Women in Pharmacology of Ion Channels and Channelopathies: 2021
At present, according to UNESCO, less than 30% of researchers worldwide are women. Long-standing biases and gender stereotypes are discouraging girls and women away from science-related fields, and STEM research in particular. Science and gender equality are, however, essential to ensure sustainable development as highlighted by UNESCO. In order to change traditional mindsets, gender equality must be promoted, stereotypes defeated, and girls and women should be encouraged to pursue STEM careers.
Therefore, Frontiers in Pharmacology is proud to offer this platform to promote the work of women scientists at different stages in their career, all over the world, and across all fields of Pharmacology.
The work presented here highlights the diversity of research performed across the entire breadth of Pharmacoepidemiology research and presents advances in theory, experiment, and methodology with applications to compelling problems. For this Topic, we will be welcoming manuscripts covering:
• Post-marketing observational studies on medications
• Post-marketing studies in populations routinely excluded from clinical trials such as children, pregnant women, and elderlies
• Observational studies on First Nations, racialized groups, and immigrant populations
• Real-world evidence using large population-based administrative or clinical databases
• Pharmacoepidemiologic real world evidence methodology
• Novel pharmacoepidemiologic methodology such as artificial intelligence and deep learning models
• Pharmacoeconomic studies
Please note: to be considered for this collection, the first or last author should be a researcher who identifies as a woman.
Different Article Types can be submitted to the Research Topic including Original Research, Review, Mini-Review, Brief Research Report, Perspective articles, among others. You can find detailed information here.
This Research Topic is part of the Women in Pharmacology series. Other titles in the series are:
Women in Obstetric and Pediatric Pharmacology: 2021
Women in Inflammation Pharmacology: 2021
Women in Integrative and Regenerative Pharmacology: 2021
Women in Pharmacology of Anti-Cancer Drugs: 2021
Women in Pharmacology of Infectious Diseases: 2021
Women in Drug Metabolism and Transport: 2021
Women in Cardiovascular and Smooth Muscle Pharmacology: 2021
Women in Inflammation Pharmacology: 2021
Women in Pharmacogenetics and Pharmacogenomics: 2021
Women in Neuropharmacology: 2021
Women in Drugs Outcomes Research and Policies: 2021
Women in Pharmacology of Ion Channels and Channelopathies: 2021
At present, according to UNESCO, less than 30% of researchers worldwide are women. Long-standing biases and gender stereotypes are discouraging girls and women away from science-related fields, and STEM research in particular. Science and gender equality are, however, essential to ensure sustainable development as highlighted by UNESCO. In order to change traditional mindsets, gender equality must be promoted, stereotypes defeated, and girls and women should be encouraged to pursue STEM careers.
Therefore, Frontiers in Pharmacology is proud to offer this platform to promote the work of women scientists at different stages in their career, all over the world, and across all fields of Pharmacology.
The work presented here highlights the diversity of research performed across the entire breadth of Pharmacoepidemiology research and presents advances in theory, experiment, and methodology with applications to compelling problems. For this Topic, we will be welcoming manuscripts covering:
• Post-marketing observational studies on medications
• Post-marketing studies in populations routinely excluded from clinical trials such as children, pregnant women, and elderlies
• Observational studies on First Nations, racialized groups, and immigrant populations
• Real-world evidence using large population-based administrative or clinical databases
• Pharmacoepidemiologic real world evidence methodology
• Novel pharmacoepidemiologic methodology such as artificial intelligence and deep learning models
• Pharmacoeconomic studies
Please note: to be considered for this collection, the first or last author should be a researcher who identifies as a woman.
Different Article Types can be submitted to the Research Topic including Original Research, Review, Mini-Review, Brief Research Report, Perspective articles, among others. You can find detailed information here.
Keywords: Women in, Pharmacoepidemiology, Women in Pharmacoepidemiology, Pharmacology, Women in Science
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
